Remdesivir and COVID-19 : what are the implications for Africa?

dc.contributor.author	Green, Robin J.
dc.contributor.author	Mustafa, Fatima
dc.contributor.author	Sewlall, Nivesh
dc.contributor.author	Richards, Guy A.
dc.date.accessioned	2021-03-24T10:12:59Z
dc.date.available	2021-03-24T10:12:59Z
dc.date.issued	2020-06
dc.description.abstract	We feel compelled to point out a few inconsistencies in new reports surfacing to support the use of remdesivir in the COVID-19 crisis.	en_ZA
dc.description.department	Paediatrics and Child Health	en_ZA
dc.description.librarian	am2021	en_ZA
dc.description.uri	http://www.samj.org.za	en_ZA
dc.identifier.citation	Green, R.J., Mustafa, F., Sewlall, N. et al. 2020, ' Remdesivir and COVID-19 : what are the implications for Africa?', South African Medical Journal, vol. 110, no. 6, pp. 447-448.	en_ZA
dc.identifier.issn	0256-9574 (print)
dc.identifier.issn	2078-5135 (online)
dc.identifier.other	10.7196/SAMJ.2020. v110i6.14889
dc.identifier.uri	http://hdl.handle.net/2263/79060
dc.language.iso	en	en_ZA
dc.publisher	Health and Medical Publishing Group	en_ZA
dc.rights	© 2019, South African Medical Association. This article is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0).	en_ZA
dc.subject	Remdesivir	en_ZA
dc.subject	Crisis	en_ZA
dc.subject	COVID-19 pandemic	en_ZA
dc.subject	Coronavirus disease 2019 (COVID-19)	en_ZA
dc.subject	South Africa (SA)	en_ZA
dc.subject	National Institute of Allergy and Infectious Diseases (NIAID)	en_ZA
dc.title	Remdesivir and COVID-19 : what are the implications for Africa?	en_ZA
dc.type	Article	en_ZA